These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18310396)

  • 1. Possible mechanisms underlying the development of cachexia in COPD.
    Wagner PD
    Eur Respir J; 2008 Mar; 31(3):492-501. PubMed ID: 18310396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.
    Broekhuizen R; Grimble RF; Howell WM; Shale DJ; Creutzberg EC; Wouters EF; Schols AM
    Am J Clin Nutr; 2005 Nov; 82(5):1059-64. PubMed ID: 16280439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status in chronic obstructive pulmonary disease: role of hypoxia.
    Raguso CA; Luthy C
    Nutrition; 2011 Feb; 27(2):138-43. PubMed ID: 21145207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
    Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
    Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
    Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
    Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of cachexia underlying muscle dysfunction in COPD.
    Remels AH; Gosker HR; Langen RC; Schols AM
    J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic effects in COPD.
    Wouters EF; Creutzberg EC; Schols AM
    Chest; 2002 May; 121(5 Suppl):127S-130S. PubMed ID: 12010840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trophologic insufficiency and absorptive function of small intestine in patients with chronic obstructive pulmonary disease].
    Beloborodova EI; Akimova LA; Asanova AV; Cherniavskaia GM; Burkovskaia VA; Ustiuzhanina EA; Semenenko EV; Naumova EL
    Klin Med (Mosk); 2009; 87(3):59-63. PubMed ID: 19469260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cachexia and related components on pulmonary functions in patients with COPD.
    Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
    Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomechanism of cachexia in chronic obstructive pulmonary disease].
    Jarzab J; Chwist-Nowak A; Rozentryt P; Chwist J
    Wiad Lek; 2005; 58(11-12):647-51. PubMed ID: 16594476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation in chronic obstructive pulmonary disease and lung cancer: common driver of pulmonary cachexia?
    Ceelen JJ; Langen RC; Schols AM
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):339-45. PubMed ID: 25158627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician.
    De Brandt J; Beijers RJHCG; Chiles J; Maddocks M; McDonald MN; Schols AMWJ; Nyberg A
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2957-2976. PubMed ID: 36425061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary cachexia.
    Schols AM
    Int J Cardiol; 2002 Sep; 85(1):101-10. PubMed ID: 12163214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease.
    Schols A
    Proc Nutr Soc; 2003 Nov; 62(4):783-91. PubMed ID: 15018476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?
    Berry JK; Baum C
    Drugs; 2004; 64(10):1041-52. PubMed ID: 15139785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossroads of cytokine signaling--the chase to stop muscle cachexia.
    Pajak B; Orzechowska S; Pijet B; Pijet M; Pogorzelska A; Gajkowska B; Orzechowski A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():251-64. PubMed ID: 19261984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.